期刊文献+

利培酮对大鼠各脑区组织BDNF-TrkB信号通路的影响 被引量:3

Effect of Risperidone on BDNF-TrkB Signaling Pathway in Rat Brain
原文传递
导出
摘要 目的探索非典型抗精神病药利培酮对大鼠脑区中脑源性神经生长因子(brain-derived neurotrophic factor,BDNF)及其受体酪氨酸激酶受体B(tyrosine kinase receptor,TrkB)、P75神经营养因子受体(P75neurotrophin receptor,P75NTR)的调控作用。方法将大鼠随机分为利培酮处理组(n=8)和对照组(n=8),利培酮处理组采用0.25mg/kg利培酮腹腔内注射,对照组采用等量安慰剂腹腔内注射,连续处理14d后处死大鼠。取大鼠左右前额叶皮质、左右颞叶皮质及海马,提取RNA并进行BDNF、TrκB和P75 NTR mRNA的实时荧光定量PCR分析。结果利培酮处理组大鼠的左右前额叶皮质、左右颞叶皮质及海马中BDNF及TrkB mRNA的表达水平较对照组增高(P<0.05),而利培酮处理组P75 NTR mRNA的表达与对照组间差异无统计学意义(P>0.05)。结论利培酮能够上调大鼠左右前额叶皮质、左右颞叶皮质及海马BDNF-TrkB信号通路,而不能改变上述脑区中P75 NTR mRNA的表达水平。 Objective To investigate the effect of risperidone on the expression of brain-derived neurotrophic factor(BDNF)and its receptors,tyrosine kinase receptor(TrkB)and P75 neurotrophin receptor(P75NTR)in rat brain.Methods Sixteen SD rats were divided into two groups(n=8for each group).The rats in experimental group were treated with risperidone〔0.25mg/(kg·d)〕for 14 d,while the control group was given placebo.Total RNA sample in prefrontal cortex,temporal cortex and hippocampus was extracted,and the expression of BDNF,TrkBand P75 NTR mRNA were determined by quantitative real-time PCR.Results The treatment of risperidone significantly up-regulated the expressions of BDNF and TrkB in prefrontal cortex,temporal cortex and hippocampus,while the expression of P75 NTR was not significantly changed. Conclusion Risperidone upregulated BDNF-TrkB signaling,but not BDNF-P75 NTR signaling,which may be helpful for the further pharmacological study of risperidone.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2015年第4期528-532,610,共6页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(No.81071089 No.81201042) 2013年度高等学校博士学科点专项科研基金(新教师类)(No.20130181120032)资助
  • 相关文献

参考文献41

  • 1Goldner EM, Hsu L, Waraich P, et al. Prevalence and incidence studies of schizophrenic disorders., a systematic review of the literature. Can J Psychiatry, 2002 , 47 (9) : 833- 843.
  • 2Wright IC, Rabe-Hesketh S, Woodruff PW, et al. Meta- analysis of regional brain volumes in schizophrenia. Am J Psychiatry, 2000 ,157(1) : 16-25.
  • 3Wright IC, Ellison ZR, Sharma T, et al. Mapping of grey matter changes in schizophrenia. Schizophr Res, 1999 ~ 35 (1) 1-14.
  • 4Chiapponi C, Piras F, Piras F, et al. Cortical grey matter and subcortical white matter brain microstructural changes in schizophrenia are localised and age independent: a case-control diffusion tensor imaging study. PLoS One, 2013~ 8 (10)~ e75115, doi: 10. 1371/journal. pone. 0075115.
  • 5Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry, 1998 ~ 55(3) : 215-224.
  • 6Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry, 1997 ; 54(10) : 943-952.
  • 7Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry, 2000 ~ 57 (1) : 65-73.
  • 8Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience, 1995 ~ 69(2) : 339-343.
  • 9Jarskog LF. Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Curr Opin Psychiatry, 2006 ~ 19(3) : 307-312.
  • 10Voineskos D, Rogaseh NC, Rajji TK, et al. A review of evidence linking disrupted neural plasticity to schizophrenia. Can J Psychiatry, 2013 ~ 58(2) ~ 86-92.

同被引文献18

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部